Kellner Capital LLC Acquires 17,600 Shares of Aetna (AET)
Kellner Capital LLC raised its position in Aetna (NYSE:AET) by 100.6% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 35,100 shares of the company’s stock after purchasing an additional 17,600 shares during the period. Aetna makes up about 3.6% of Kellner Capital LLC’s investment portfolio, making the stock its 9th biggest holding. Kellner Capital LLC’s holdings in Aetna were worth $5,932,000 at the end of the most recent reporting period.
A number of other large investors have also recently modified their holdings of AET. Pennsylvania Trust Co bought a new stake in Aetna in the fourth quarter valued at approximately $200,000. Davis R M Inc. bought a new stake in Aetna in the fourth quarter valued at approximately $218,000. Bank of Montreal Can increased its stake in Aetna by 67.2% in the fourth quarter. Bank of Montreal Can now owns 462,914 shares of the company’s stock valued at $83,504,000 after purchasing an additional 186,033 shares in the last quarter. Creative Planning increased its stake in Aetna by 9.2% in the fourth quarter. Creative Planning now owns 19,748 shares of the company’s stock valued at $3,562,000 after purchasing an additional 1,666 shares in the last quarter. Finally, Coastline Trust Co bought a new stake in Aetna in the fourth quarter valued at approximately $226,000. 87.01% of the stock is owned by hedge funds and other institutional investors.
Several equities research analysts have commented on the stock. Credit Suisse Group upped their target price on shares of Aetna from $200.00 to $208.00 and gave the company a “neutral” rating in a research note on Wednesday, January 31st. Citigroup downgraded shares of Aetna from a “buy” rating to a “neutral” rating and upped their target price for the company from $187.89 to $212.00 in a research note on Wednesday, January 31st. Cowen reaffirmed a “buy” rating and issued a $212.00 target price on shares of Aetna in a research note on Tuesday, January 30th. Piper Jaffray reaffirmed a “buy” rating and issued a $212.00 target price on shares of Aetna in a research note on Tuesday, January 30th. Finally, Deutsche Bank raised shares of Aetna from a “hold” rating to a “buy” rating and upped their target price for the company from $195.00 to $212.00 in a research note on Monday, January 22nd. Eight analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $196.36.
Aetna (NYSE:AET) last issued its quarterly earnings data on Tuesday, May 1st. The company reported $3.19 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.97 by $0.22. Aetna had a net margin of 5.76% and a return on equity of 21.42%. The company had revenue of $15.34 billion during the quarter, compared to the consensus estimate of $15.32 billion. During the same quarter in the prior year, the firm earned $2.71 earnings per share. The firm’s revenue was up 1.1% compared to the same quarter last year. research analysts anticipate that Aetna will post 11.06 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Friday, April 27th. Investors of record on Thursday, April 12th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.13%. The ex-dividend date was Wednesday, April 11th. Aetna’s payout ratio is 20.28%.
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.